Preview
Sign-in for full Details 
Sign-in free and Explore the Exciting World of BiomedExperts:
- Over 1.500.000 Profiles
- More than 1.800 Organizations worldwide
- State of the Art Network Visualizations
- Manage your own Profile
- Locate Experts in your Country/Region
- Locate Experts in your 1. and 2. Level Network
- Connect to Experts Worldwide
NetworkView
Philip Kemp
This is a preview profile on BiomedExperts - the first literature-based scientific social network. It brings the right researchers
together and allows them to collaborate online. Collexis and Dell provide the BiomedExperts network of +1.5 Million pre-calculated profiles
free of charge to researchers worldwide.
Research Profile (preview)
Living Beings
Physiology
Disorders
Chemicals & Drugs
Phenomena
Anatomy
Sign-in to see full Profile
Network (preview)
84
Gardiner, Sheila
81
Bennett, Terence
51
March, Julie
3
Davenport, Anthony
3
Ballard, Stephen
2
Bennett, T
2
Rubin, PC
1
Valentin, Jean-Pierre
1
Wakefield, Ian
1
Auton, Tim
1
Fry, Jeffrey
1
McCulloch, Audrey
1
Randall, Michael
1
Alexander, S P H
1
Glover, James
Sign-in to see all Coauthors
Publications
Sign-in to see all Publications
Sign in free and see...
Visualized networks:
See your personal network in
sophisticated graphical views
GeoTargeted Searches:
Locate experts around the world
and connect with global collaborators
Research Profiles:
See the visualized research activity
of experts around the globe
Sign-in to see more
Geonetwork of Philip Kemp (preview)
Cities where this author has publications
Cities where co-authors of this author have publications
Sign-in to see more
All Publications
-
2009: Gardiner S M; March J E; Kemp P A; Bennett T
Factors influencing the regional haemodynamic responses to methanandamide and anandamide in conscious rats.
British journal of pharmacology 2009;158(4):1143-52.
-
2009: Jolly L; March J E; Kemp P A; Bennett T; Gardiner S M
Mechanisms involved in the regional haemodynamic effects of intermedin (adrenomedullin 2) compared with adrenomedullin in conscious rats.
British journal of pharmacology 2009;157(8):1502-13.
-
2008: Jolly L; March J E; Kemp P A; Bennett T; Gardiner S M
Regional haemodynamic responses to adenosine receptor activation vary across time following lipopolysaccharide treatment in conscious rats.
British journal of pharmacology 2008;154(8):1600-10.
-
2008: Gardiner S M; March J E; Kemp P A; Bennett T
Autonomic nervous system-dependent and -independent cardiovascular effects of exendin-4 infusion in conscious rats.
British journal of pharmacology 2008;154(1):60-71.
-
2007: Gardiner S M; March J E; Kemp P A; Bennett T
A comparison between the cardiovascular actions of urocortin 1 and urocortin 2 (stresscopin-related peptide) in conscious rats.
The Journal of pharmacology and experimental therapeutics 2007;321(1):221-6.
-
2006: Gardiner S M; March J E; Kemp P A; Bennett T
Effects of nitric oxide synthase inhibition with or without cyclooxygenase-2 inhibition on resting haemodynamics and responses to exendin-4.
British journal of pharmacology 2006;149(6):802-9.
-
2006: Gardiner S M; March J E; Kemp P A; Ballard S A; Bennett T
Regional hemodynamic effects of neutral endopeptidase inhibition and angiotensin (AT(1)) receptor antagonism alone or in combination in conscious spontaneously hypertensive rats.
The Journal of pharmacology and experimental therapeutics 2006;319(1):340-8.
-
2006: Gardiner Sheila M; March Julie E; Kemp Philip A; Maguire Janet J; Kuc Rhoda E; Davenport Anthony P; Bennett Terence
Regional heterogeneity in the haemodynamic responses to urotensin II infusion in relation to UT receptor localisation.
British journal of pharmacology 2006;147(6):612-21.
-
2006: Gardiner Sheila M; March Julie E; Kemp Philip A; Bennett Terence
Mesenteric vasoconstriction and hindquarters vasodilatation accompany the pressor actions of exendin-4 in conscious rats.
The Journal of pharmacology and experimental therapeutics 2006;316(2):852-9.
-
2005: Gardiner S M; March J E; Kemp P A; Bennett T
Involvement of CB1-receptors and beta-adrenoceptors in the regional hemodynamic responses to lipopolysaccharide infusion in conscious rats.
American journal of physiology. Heart and circulatory physiology 2005;288(5):H2280-8.
-
2005: Gardiner S M; March J E; Kemp P A; Ballard S A; Hawkeswood E; Hughes B; Bennett T
Hemodynamic effects of phosphodiesterase 5 and angiotensin-converting enzyme inhibition alone or in combination in conscious SHR.
The Journal of pharmacology and experimental therapeutics 2005;312(1):265-71.
-
2005: Gardiner Sheila M; March Julie E; Kemp Philip A; Davenport Anthony P; Wiley Katherine E; Bennett Terence
Regional hemodynamic actions of selective corticotropin-releasing factor type 2 receptor ligands in conscious rats.
The Journal of pharmacology and experimental therapeutics 2005;312(1):53-60.
-
2004: Gardiner Sheila M; March Julie E; Kemp Philip A; Bennett Terence
Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response.
British journal of pharmacology 2004;143(3):422-30.
-
2004: Bennett T; Mahajan R P; March J E; Kemp P A; Gardiner S M
Regional and temporal changes in cardiovascular responses to norepinephrine and vasopressin during continuous infusion of lipopolysaccharide in conscious rats.
British journal of anaesthesia 2004;93(3):400-7.
-
2004: Gardiner S M; March J E; Kemp P A; Fallgren B; Bennett T
Regional haemodynamic effects of cyclosporine A, tacrolimus and sirolimus in conscious rats.
British journal of pharmacology 2004;141(4):634-43.
-
2004: Gardiner Sheila M; March Julie E; Kemp Philip A; Ballard Stephen A; Hawkeswood Ed; Hughes Bernadette; Bennett Terence
Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK-357,903, in conscious SHR.
British journal of pharmacology 2004;141(1):114-22.
-
2003: Wakefield Ian D; March Julie E; Kemp Philip A; Valentin Jean-Pierre; Bennett Terence; Gardiner Sheila M
Comparative regional haemodynamic effects of the nitric oxide synthase inhibitors, S-methyl-L-thiocitrulline and L-NAME, in conscious rats.
British journal of pharmacology 2003;139(6):1235-43.
-
2002: Gardiner S M; March J E; Kemp P A; Bennett T
Influence of the CB(1) receptor antagonist, AM 251, on the regional haemodynamic effects of WIN-55212-2 or HU 210 in conscious rats.
British journal of pharmacology 2002;136(4):581-7.
-
2002: Gardiner S M; March J E; Kemp P A; Bennett T
Complex regional haemodynamic effects of anandamide in conscious rats.
British journal of pharmacology 2002;135(8):1889-96.
-
2001: Gardiner S M; March J E; Kemp P A; Bennett T
Effects of the novel selective endothelin ET(A) receptor antagonist, SB 234551, on the cardiovascular responses to endotoxaemia in conscious rats.
British journal of pharmacology 2001;133(8):1371-7.
-
2001: Gardiner S M; March J E; Kemp P A; Bennett T
Regional haemodynamic responses to the cannabinoid agonist, WIN 55212-2, in conscious, normotensive rats, and in hypertensive, transgenic rats.
British journal of pharmacology 2001;133(3):445-53.
-
2001: Gardiner S M; March J E; Kemp P A; Davenport A P; Bennett T
Depressor and regionally-selective vasodilator effects of human and rat urotensin II in conscious rats.
British journal of pharmacology 2001;132(8):1625-9.
-
2000: Gardiner S M; March J E; Kemp P A; Bennett T
Cardiovascular effects of endothelin-1 and endothelin antagonists in conscious, hypertensive ((mRen-2)27) rats.
British journal of pharmacology 2000;131(8):1732-8.
-
2000: Gardiner S M; Kemp P A; March J E; Bennett T
Regional haemodynamic effects of recombinant murine or human leptin in conscious rats.
British journal of pharmacology 2000;130(4):805-10.
-
2000: Gardiner S M; Auton T R; Downham M R; Sharp H L; Kemp P A; March J E; Martin H; Morgan P J; Rushton A; Bennett T; Glover J F
Active immunization with angiotensin I peptide analogue vaccines selectively reduces the pressor effects of exogenous angiotensin I in conscious rats.
British journal of pharmacology 2000;129(6):1178-82.
-
1999: Gardiner S M; March J E; Kemp P A; Bennett T
Cardiovascular responses to angiotensins I and II in normotensive and hypertensive rats; effects of NO synthase inhibition or ET receptor antagonism.
British journal of pharmacology 1999;128(8):1795-803.
-
1999: Gardiner S M; Kemp P A; March J E; Bennett T
Regional haemodynamic responses to infusion of lipopolysaccharide in conscious rats: effects of pre- or post-treatment with glibenclamide.
British journal of pharmacology 1999;128(8):1772-8.
-
1999: Gardiner S M; March J E; Kemp P A; Bennett T
Influence of CGRP (8-37), but not adrenomedullin (22-52), on the haemodynamic responses to lipopolysaccharide in conscious rats.
British journal of pharmacology 1999;127(7):1611-8.
-
1999: Gardiner S M; Kemp P A; March J E; Bennett T
Influence of FR 167653, an inhibitor of TNF-alpha and IL-1, on the cardiovascular responses to chronic infusion of lipopolysaccharide in conscious rats.
Journal of cardiovascular pharmacology 1999;34(1):64-9.
-
1999: Kemp P A; Gardiner S M; March J E; Rubin P C; Bennett T
Assessment of the effects of endothelin-1 and magnesium sulphate on regional blood flows in conscious rats, by the coloured microsphere reference technique.
British journal of pharmacology 1999;126(3):621-6.
-
1998: Gardiner S M; Kemp P A; March J E; Woolley J; Bennett T
The influence of antibodies to TNF-alpha and IL-1beta on haemodynamic responses to the cytokines, and to lipopolysaccharide, in conscious rats.
British journal of pharmacology 1998;125(7):1543-50.
-
1998: Gardiner S M; March J E; Kemp P A; Bennett T
The contribution of nitric oxide to cardiovascular status and responses to vasodilators in conscious, hypertensive, transgenic ((mRen-2)27) rats.
British journal of pharmacology 1998;124(2):299-306.
-
1998: Gardiner S M; Kemp P A; March J E; Bennett T
Enhanced involvement of endothelin in the haemodynamic sequelae of endotoxaemia in conscious, hypertensive, transgenic ((mRen-2)27) rats.
British journal of pharmacology 1998;123(7):1403-8.
-
1997: Gardiner S M; Kemp P A; Brunner-Ferber F; Bennett T
Comparative effects of the dual metallopeptidase inhibitor, MDL 100,240 and of enalaprilat on regional and on cardiac haemodynamics in conscious, hypertensive, transgenic ((mRen-2)27) rats.
British journal of pharmacology 1997;122(8):1694-701.
-
1997: Gardiner S M; Kemp P A; Brunner-Ferber F; Bennett T
Effects of the dual metallopeptidase inhibitor, MDL 100,240, on regional haemodynamic responses to vasoactive peptides in conscious rats.
British journal of pharmacology 1997;122(8):1687-93.
-
1996: Gardiner S M; Kemp P A; March J E; Bennett T
Temporal differences between the involvement of angiotensin II and endothelin in the cardiovascular responses to endotoxaemia in conscious rats.
British journal of pharmacology 1996;119(8):1619-27.
-
1996: Randall M D; Alexander S P; Bennett T; Boyd E A; Fry J R; Gardiner S M; Kemp P A; McCulloch A I; Kendall D A
An endogenous cannabinoid as an endothelium-derived vasorelaxant.
Biochemical and biophysical research communications 1996;229(1):114-20.
-
1996: Gardiner S M; Kemp P A; March J E; Bennett T
Influence of aminoguanidine and the endothelin antagonist, SB 209670, on the regional haemodynamic effects of endotoxaemia in conscious rats.
British journal of pharmacology 1996;118(7):1822-8.
-
1996: Gardiner S M; Kemp P A; March J E; Bennett T
Effects of the non-peptide, non-selective endothelin antagonist, bosentan, on regional haemodynamic responses to NG-monomethyl-L-arginine in conscious rats.
British journal of pharmacology 1996;118(2):352-4.
-
1996: Gardiner S M; March J E; Kemp P A; Bennett T
Regional haemodynamic effects of antagonists of angiotensin II, endothelin and adrenoceptors in conscious, vasopressin-deficient, genetically hypertensive rats.
British journal of pharmacology 1996;118(2):325-34.
-
1996: Gardiner S M; Kemp P A; March J E; Bennett T
Effects of dexamethasone and SB 209670 on the regional haemodynamic responses to lipopolysaccharide in conscious rats.
British journal of pharmacology 1996;118(1):141-9.
-
1996: Gardiner S M; Kemp P A; March J E; Fallgren B; Bennett T
Effects of glibenclamide on the regional haemodynamic actions of alpha-trinositol and its influence on responses to vasodilators in conscious rats.
British journal of pharmacology 1996;117(3):507-515.
-
1995: Gardiner S M; Kemp P A; March J E; Bennett T
Enhancement of the haemodynamic effects of NG-monomethyl-L-arginine by transforming growth factor-beta 1 in conscious, normal, but not endotoxaemic, rats.
British journal of pharmacology 1995;116(7):3042-8.
-
1995: Gardiner S M; Kemp P A; March J E; Bennett T
Cardiac and regional haemodynamics, inducible nitric oxide synthase (NOS) activity, and the effects of NOS inhibitors in conscious, endotoxaemic rats.
British journal of pharmacology 1995;116(3):2005-16.
-
1995: Gardiner S M; March J E; Kemp P A; Mullins J J; Bennett T
Haemodynamic effects of losartan and the endothelin antagonist, SB 209670, in conscious, transgenic ((mRen-2)27), hypertensive rats.
British journal of pharmacology 1995;116(4):2237-44.
-
1995: Gardiner S M; Kemp P A; March J E; Bennett T
Enhancement of the hypotensive and vasodilator effects of endotoxaemia in conscious rats by the endothelin antagonist, SB 209670.
British journal of pharmacology 1995;116(2):1718-9.
-
1995: Gardiner S M; Kemp P A; March J E; Bennett T
Acute and chronic cardiac and regional haemodynamic effects of the novel bradycardic agent, S16257, in conscious rats.
British journal of pharmacology 1995;115(4):579-86.
-
1995: Gardiner S M; Kemp P A; March J E; Bennett T
Regional haemodynamic effects of human and rat adrenomedullin in conscious rats.
British journal of pharmacology 1995;114(3):584-91.
-
1994: Gardiner S M; March J E; Kemp P A; Bennett T
Resting cardiovascular status and vasodilator function in a vasopressin-deficient, hypertensive strain of rat.
Journal of hypertension 1994;12(11):1217-24.
-
1994: Gardiner S M; Kemp P A; Fallgren B; Bennett T
Effects of chronic infusions of alpha-trinositol on regional and cardiac haemodynamics in conscious rats.
British journal of pharmacology 1994;113(1):129-36.
-
1994: Gardiner S M; Kemp P A; March J E; Bennett T
Effects of bosentan (Ro 47-0203), an ETA-, ETB-receptor antagonist, on regional haemodynamic responses to endothelins in conscious rats.
British journal of pharmacology 1994;112(3):823-30.
-
1994: Gardiner S M; Kemp P A; March J E; Bennett T; Davenport A P; Edvinsson L
Effects of an ET1-receptor antagonist, FR139317, on regional haemodynamic responses to endothelin-1 and [Ala11,15]Ac-endothelin-1 (6-21) in conscious rats.
British journal of pharmacology 1994;112(2):477-86.
-
1994: Bachelard H; Gardiner S M; Kemp P A; Bennett T
Regional haemodynamic effects of carbachol injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats.
Neuropharmacology 1994;33(6):769-88.
-
1994: Gardiner S M; Rakhit T; Kemp P A; March J E; Bennett T
Regional haemodynamic responses to pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide in conscious rats.
British journal of pharmacology 1994;111(2):589-97.
-
1994: Kemp P A; Gardiner S M; March J E; Bennett T; Rubin P C
Effects of NG-nitro-L-arginine methyl ester on regional haemodynamic responses to MgSO4 in conscious rats.
British journal of pharmacology 1994;111(1):325-31.
-
1993: Gardiner S M; Kemp P A; Bennett T
Regional haemodynamic responses to intravenous and intraarterial endothelin-1 and big endothelin-1 in conscious rats.
British journal of pharmacology 1993;110(4):1532-6.
-
1993: Gardiner S M; Kemp P A; Bennett T; Palmer R M; Moncada S
Regional and cardiac haemodynamic effects of NG, NG,dimethyl-L-arginine and their reversibility by vasodilators in conscious rats.
British journal of pharmacology 1993;110(4):1457-64.
-
1993: Gardiner S M; Kemp P A; March J E; Bennett T
Regional haemodynamic effects of angiotensin II (3-8) in conscious rats.
British journal of pharmacology 1993;110(1):159-62.
-
1993: Gardiner S M; Kemp P A; Bennett T
Regional haemodynamics in Brattleboro rats during chronic ingestion of NG-nitro-L-arginine methyl ester.
Blood pressure 1993;2(3):228-32.
-
1993: Kemp P A; Gardiner S M; Bennett T; Rubin P C
Magnesium sulphate reverses the carotid vasoconstriction caused by endothelin-I, angiotensin II and neuropeptide-Y, but not that caused by NG-nitro-L-arginine methyl ester, in conscious rats.
Clinical science (London, England : 1979) 1993;85(2):175-81.
-
1993: Widdop R E; Gardiner S M; Kemp P A; Bennett T
Differential blockade of central effects of angiotensin II by AT2-receptor antagonists.
The American journal of physiology 1993;265(1 Pt 2):H226-31.
-
1993: Gardiner S M; Kemp P A; Bennett T
Effects of chronic treatment with nitric oxide synthase inhibitors on regional haemodynamic responses to vasodilators in conscious Brattleboro rats.
British journal of pharmacology 1993;109(1):222-8.
-
1993: Gardiner S M; Kemp P A; Bennett T
Differential effects of captopril on regional haemodynamic responses to angiotensin I and bradykinin in conscious rats.
British journal of pharmacology 1993;108(3):769-75.
-
1993: Widdop R E; Gardiner S M; Kemp P A; Bennett T
Comparison of the regional haemodynamic effects of the AT1-receptor antagonists, losartan and EXP 3174, in water-deprived Brattleboro rats.
British journal of pharmacology 1993;108(3):684-8.
-
1993: Widdop R E; Gardiner S M; Kemp P A; Bennett T
Central administration of PD 123319 or EXP-3174 inhibits effects of angiotensin II.
The American journal of physiology 1993;264(1 Pt 2):H117-25.
-
1992: Widdop R E; Gardiner S M; Kemp P A; Bennett T
Inhibition of the haemodynamic effects of angiotensin II in conscious rats by AT2-receptor antagonists given after the AT1-receptor antagonist, EXP 3174.
British journal of pharmacology 1992;107(3):873-80.
-
1992: Gardiner S M; Kemp P A; Bennett T
Inhibition by phosphoramidon of the regional haemodynamic effects of proendothelin-2 and -3 in conscious rats.
British journal of pharmacology 1992;107(2):584-90.
-
1992: Gardiner S M; Kemp P A; Compton A M; Bennett T
Coeliac haemodynamic effects of endothelin-1, endothelin-3, proendothelin-1 [1-38] and proendothelin-3 [1-41] in conscious rats.
British journal of pharmacology 1992;106(2):483-8.
-
1992: Gardiner S M; Kemp P A; Bennett T
Effects of the neutral endopeptidase inhibitor, SQ 28,603, on regional haemodynamic responses to atrial natriuretic peptide or proendothelin-1 [1-38] in conscious rats.
British journal of pharmacology 1992;106(1):180-6.
-
1992: Gardiner S M; Kemp P A; Bennett T; Bose C; Foulkes R; Hughes B
Involvement of beta 2-adrenoceptors in the regional haemodynamic responses to bradykinin in conscious rats.
British journal of pharmacology 1992;105(4):839-48.
-
1992: Widdop R E; Gardiner S M; Kemp P A; Bennett T
The influence of atropine and atenolol on the cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.
British journal of pharmacology 1992;105(3):653-6.
-
1992: Gardiner S M; Kemp P A; Bennett T; Palmer R M; Moncada S
Nitric oxide synthase inhibitors cause sustained, but reversible, hypertension and hindquarters vasoconstriction in Brattleboro rats.
European journal of pharmacology 1992;213(3):449-51.
-
1992: Bachelard H; Gardiner S M; Kemp P A; Bennett T
Mechanisms contributing to the regional haemodynamic effects of neurotensin in conscious, unrestrained Long Evans rats.
British journal of pharmacology 1992;105(1):191-201.
-
1992: Bachelard H; Gardiner S M; Kemp P A; Bennett T
Involvement of capsaicin-sensitive neurones in the haemodynamic effects of exogenous vasoactive peptides: studies in conscious, adult Long Evans rats treated neonatally with capsaicin.
British journal of pharmacology 1992;105(1):202-10.
-
1992: Bachelard H; Harland D; Gardiner S M; Kemp P A; Bennett T
Regional haemodynamic effects of noradrenaline injected into the hypothalamic paraventricular nuclei of conscious, unrestrained rats: possible mechanisms of action.
Neuroscience 1992;47(4):941-57.
-
1991: Gardiner S M; Kemp P A; Bennett T
Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to adrenaline or BRL 38227 in conscious rats.
British journal of pharmacology 1991;104(3):731-7.
-
1991: Phillips K; Gardiner S M; Kemp P A; Bennett T
Factors affecting the regional haemodynamic responses to glyceryl trinitrate and molsidomine in conscious rats.
British journal of pharmacology 1991;104(1):151-8.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T
The effects of phosphoramidon on the regional haemodynamic responses to human proendothelin [1-38] in conscious rats.
British journal of pharmacology 1991;103(4):2009-15.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T; Bose C; Foulkes R; Hughes B
Antagonistic effect of human alpha-calcitonin gene-related peptide (8-37) on regional hemodynamic actions of rat islet amyloid polypeptide in conscious Long-Evans rats.
Diabetes 1991;40(8):948-51.
-
1991: Gardiner S M; Kemp P A; Bennett T
Effects of NG-nitro-L-arginine methyl ester on vasodilator responses to acetylcholine, 5'-N-ethylcarboxamidoadenosine or salbutamol in conscious rats.
British journal of pharmacology 1991;103(3):1725-32.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T; Bose C; Foulkes R; Hughes B
Human alpha-calcitonin gene-related peptide (CGRP)-(8-37), but not -(28-37), inhibits carotid vasodilator effects of human alpha-CGRP in vivo.
European journal of pharmacology 1991;199(3):375-8.
-
1991: Batin P; Gardiner S M; Compton A M; Kemp P A; Bennett T
Cardiac haemodynamic effects of the non-peptide, angiotensin II-receptor antagonist, DuP 753, in conscious Long Evans and Brattleboro rats.
British journal of pharmacology 1991;103(2):1585-91.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T; Foulkes R; Hughes B
Regional haemodynamic effects of prolonged infusions of human alpha-calcitonin gene-related peptide in conscious, Long Evans rats.
British journal of pharmacology 1991;103(2):1509-14.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T; Hughes B; Foulkes R
Differential effects of (+/-)-dobutamine and human alpha-CGRP on cardiac and on regional haemodynamics in conscious Long Evans rats.
British journal of pharmacology 1991;103(2):1500-8.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T; Foulkes R; Hughes B
Haemodynamic effects of human alpha-calcitonin gene-related peptide following administration of endothelin-1 or NG-nitro-L-arginine methyl ester in conscious rats.
British journal of pharmacology 1991;103(1):1256-62.
-
1991: Gardiner S M; Compton A M; Kemp P A; Bennett T
Effects of NG-nitro-L-arginine methyl ester or indomethacin on differential regional and cardiac haemodynamic actions of arginine vasopressin and lysine vasopressin in conscious rats.
British journal of pharmacology 1991;102(1):65-72.
-
1990: Gardiner S M; Compton A M; Kemp P A; Bennett T
Regional and cardiac haemodynamic responses to glyceryl trinitrate, acetylcholine, bradykinin and endothelin-1 in conscious rats: effects of NG-nitro-L-arginine methyl ester.
British journal of pharmacology 1990;101(3):632-9.
-
1990: Gardiner S M; Compton A M; Kemp P A; Bennett T
Regional and cardiac haemodynamic effects of NG-nitro-L-arginine methyl ester in conscious, Long Evans rats.
British journal of pharmacology 1990;101(3):625-31.
-
1990: Gardiner S M; Compton A M; Kemp P A; Bennett T; Bose C; Foulkes R; Hughes B
Antagonistic effect of human alpha-CGRP [8-37] on the in vivo regional haemodynamic actions of human alpha-CGRP.
Biochemical and biophysical research communications 1990;171(3):938-43.
-
1990: Gardiner S M; Compton A M; Kemp P A; Bennett T
Cardiac output effects of endothelin-1, -2 and -3 and sarafotoxin S6b in conscious rats.
Journal of the autonomic nervous system 1990;30(2):143-7.
-
1990: Gardiner S M; Compton A M; Bennett T; Kemp P A; Ney U
Synergistic internal carotid vasodilator effects of human alpha-calcitonin gene-related peptide and nimodipine in conscious rats.
British journal of pharmacology 1990;99(4):830-4.
Sign-in to see more